http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-00-010.html
In June 1991, this subcommittee asked TAP to provide testimony on a Cooperative Research and Development Agreement (CRADA) between Bristol-Myers Squibb (BMS) and the National Cancer Institution (NCI), regarding the development of taxol.(1) Our review of the NCI/BMS taxol CRADA was followed by a much broader review of the government's role in the development of new drugs.
For example, in a study presented in February 1993, TAP examined the federal government's role in the development of all FDA approved cancer drugs that were discovered since 1955, and found that 34 of the 37 cancer drugs were developed with significant federal support.(2)
...Of these 30 "important" new drugs approved by the FDA, 15 benefited from significant funding by the U.S. government. When one considers the country where the drug was first discovered the government's role is even more important. 17 of the "important" new drugs were discovered in the U.S. Of these drugs, 12 were developed with significant government funding - that is, 71 percent were developed with significant government funding.
http://www.cptech.org/pharm/igrep.html
Additional notes on government role in the development of HIV/AIDS drugs
http://www.cptech.org/ip/health/aids/gov-role.html
A google search returns 58,200 results